Liminal BioSciences Inc - ESG Rating & Company Profile powered by AI
The report of Liminal BioSciences Inc was assembled by All Street Sevva using proprietary artificial intelligence. If you are employed by Liminal BioSciences Inc and you would like to use your Sustainability aseessment, please get in touch. This Disclosure rating includes 17 United Nations Sustainable Development Goals including: 'Quality Education', 'Climate Action' and 'Life on Land'.
Liminal BioSciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.5; made up of an environmental score of 4.0, social score of 6.7 and governance score of 5.7.
5.5
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 808 | Tilray Inc | 5.6 | High |
| 808 | Y-mAbs Therapeutics Inc | 5.6 | High |
| 835 | Liminal BioSciences Inc | 5.5 | High |
| 835 | Animalcare Group PLC | 5.5 | High |
| 835 | Bafna Pharmaceuticals Ltd | 5.5 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Liminal BioSciences Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Liminal BioSciences Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Liminal BioSciences Inc report the average age of the workforce?
Sign up for free to unlockDoes Liminal BioSciences Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Liminal BioSciences Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Liminal BioSciences Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Liminal BioSciences Inc offer flexible work?
Sign up for free to unlockDoes Liminal BioSciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Liminal BioSciences Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Liminal BioSciences Inc conduct supply chain audits?
Sign up for free to unlockDoes Liminal BioSciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Liminal BioSciences Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Liminal BioSciences Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Liminal BioSciences Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Liminal BioSciences Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Liminal BioSciences Inc disclose water use targets?
Sign up for free to unlockDoes Liminal BioSciences Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Liminal BioSciences Inc have a product recall in the last two years?
Sign up for free to unlockDoes Liminal BioSciences Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Liminal BioSciences Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Liminal BioSciences Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Liminal BioSciences Inc disclose parental leave metrics?
Sign up for free to unlockDoes Liminal BioSciences Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Liminal BioSciences Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Liminal BioSciences Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Liminal BioSciences Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Liminal BioSciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Liminal BioSciences Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Liminal BioSciences Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Liminal BioSciences Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Liminal BioSciences Inc disclose its waste policy?
Sign up for free to unlockDoes Liminal BioSciences Inc report according to TCFD requirements?
Sign up for free to unlockDoes Liminal BioSciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Liminal BioSciences Inc disclose energy use targets?
Sign up for free to unlockDoes Liminal BioSciences Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Liminal BioSciences Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Liminal BioSciences Inc
These potential risks are based on the size, segment and geographies of the company.
Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the treatment of idiopathic pulmonary, liver, cardiac, or skin fibrosis with fezagepras or related derivatives and respiratory diseases. It is also developing antagonist candidate programs, including G-protein coupled receptor 84 and Oxo-eicosanoid receptor 1, which are in preclinical stage. The company was formerly known as Prometic Life Sciences Inc. and changed its name to Liminal BioSciences Inc. in October 2019. Liminal BioSciences Inc. was incorporated in 1994 and is headquartered in Laval, Canada.